Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ID-RCB | Other Identifier | 2026-A00316-45 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The onset of menopause is accompanied by a significant drop in blood estradiol levels, the main symptom of which is hot flashes. These are present in 80% of menopausal women and are debilitating in 25% of cases.
Although estrogen therapy is the most effective treatment for managing menopausal symptoms, numerous non-hormonal alternatives, both pharmacological and non-pharmacological, have been evaluated for managing menopausal symptoms. Among these, hypnosis has shown promise in several studies.
However, to our knowledge, there are no studies that evaluate the longer-term effectiveness of hypnotherapy on menopausal symptoms (beyond 3 months after the start of treatment). Furthermore, there is very little data on the effectiveness of hypnotherapy on the overall quality of life of these women, independent of hot flashes, nor on other symptoms related to menopause. A first pilot study, neither randomized nor controlled, is currently underway, and we hope to continue the project with a robust controlled study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard group without hypnosis | Active Comparator | Patient receiving conventional care without hypnosis |
|
| Experimental group with hypnosis | Experimental | Patient undergoing hypnosis sessions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hypnosis session | Other | For the experimental group: two hypnosis sessions with the nurse |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the effectiveness at 6 months of hypnotherapy on the overall quality of life of menopausal women compared to a simple empathic support technique. | The effectiveness of hypnotherapy in treating the side effects of menopause will be assessed with the score calculated from the MENQOL questionnaire at 6 months | 6 months after the inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluating the effectiveness of hypnotherapy on women's overall quality of life at 3 months | The effectiveness of hypnotherapy in treating the side effects of menopause will be assessed with the score calculated from the MENQOL questionnaire at 3 months | 3 months after the inclusion |
| Evaluate the effectiveness of hypnotherapy on the frequency of hot flashes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
The study concerns menopausal disorders, experienced only by women
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Christelle MOREAU | Contact | 0567771182 | +33 | moreau.c@chu-toulouse.Fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre de ménopause, Hôpital Paule de Viguier, 330 avenue Grande Bretagne | Toulouse | Oui | 31300 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Group self-hypnosis | Other | For the experimental group: reinforcement of the hypnosis technique with a group self-hypnosis session |
|
| Unstructured supportive interview | Other | For the control group: unstructured supportive interview with the nurse |
|
| Questionnaires completion | Other | Completion of quality of life questionnaires at inclusion, at 3 months and at 6 months |
|
Measurement of the total number of hot flashes recorded daily over 7 days |
| 6 months after the inclusion |
| Evaluation of the tolerance of hypnotherapy | Measuring tolerance using an adverse event questionnaire | 6 months after the inclusion |
| Evaluation of the effectiveness of hypnotherapy on depressive symptoms | Depressive symptoms will be assessed using the validated Patient Health Questionnaire-9 (PHQ-9). | 6 months after the inclusion |
| Evaluation of the effectiveness of hypnotherapy on sleep disorders | Sleep disorders will be assessed using the Insomnia Severity Index (ISI) questionnaire. | 6 months after the inclusion |